To further confirm the effects of NAT10 activity on the proliferation of prostate cancer cells, AR-positive VCaP and AR-negative PC-3 cells were treated with Remodelin and subsequently evaluated using the MTS method. Here, NAT10 is linked to prostate carcinoma.